
How Bird Flu Became a Human Pandemic Threat
Rachel Feltman: For Scientific American 's Science Quickly, I'm Rachel Feltman.
H5N1 bird flu has been making a lot of headlines since last year, and for good reason: since March 2024 this subtype of bird flu has infected upwards of 1,000 herds of dairy cattle, raising concerns about the virus's ability to pass between mammals.
This week Science Quickly is doing a three-part deep dive to bring you the latest research on bird flu. From visiting dairy farms to touring cutting-edge virology labs we'll explore what scientists have learned about bird flu—and why it poses such a potential risk to humans.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Today's episode brings us back to the start: the wild flocks where new strains of bird flu evolve and spread. Our host is Lauren Young, associate editor for health and medicine at Scientific American.
[CLIP: Birds cawing.]
Pamela McKenzie: So many red knots—it's unbelievable.
Lauren Young: Out on Norbury's Landing, a small strip of sandy beach at the southern tip of New Jersey on the Delaware Bay, Pamela McKenzie peers through her binoculars at a massive flock of shorebirds.
McKenzie: It's just, like, a sea of red bellies.
Young: A flurry of different migratory birds, including red knots, ruddy turnstones and sanderlings, are making a pit stop on their long migration up to the Arctic Circle.
The birds are just in sight, and Pam desperately wants to get closer without disturbing them. But there's a problem: the high tide has filled a small channel that's blocking our path.
Young (tape): Wow, there's, like, tons of them over there. That's wild.
McKenzie: Of course, right where we need to go.
Young: So most people go to the beach for the cool waves, the salty breeze and the sunshine. Some might go to collect seashells. But Pam is out here collecting bird poop.
Every year in mid-May she hops between the various beaches of Delaware Bay, scooping poop that just might contain avian influenza viruses. By the second day of this year's collection her team had already found samples that came back positive for different bird flu viruses, but not the headline-making H5N1—at least not yet.
McKenzie: What's unique about Delaware Bay is that it's a hotspot for influenza. Every year these birds migrate here, and we find influenza—and different influenza—every year.
Young: Pam is a virus detective. As director of surveillance for the St. Jude Center of Excellence for Influenza Research and Response she and her fellow research scientists take an annual visit to Delaware Bay. They do this to stay on top of the avian influenza viruses actively circulating in the flocks of migrating shorebirds.
Robert Webster: One of the very important contributions that the laboratory here at St. Jude has made was the realization that influenza in aquatic birds replicates mainly in the intestinal tract and the birds poop it out.
Young: That's Robert Webster. He first visited Delaware Bay in 1985. Robert began St. Jude's influenza surveillance research at the bay, which has continued for the last 40 years.
Webster: Vast quantities of virus [were] in the feces. And so going back to Delaware Bay we didn't have to catch the birds; we simply followed them and took fecal samples from the beach when they pooped.
Young: The reason the shorebirds are here, pooping out a lot of influenza, has to do with the full moon—the first full moon in May, to be exact. The moon's gravitational pull causes the high tides to swell, drawing in thousands of horseshoe crabs, tussling in huge mating piles along the waterline. And the birds know this is the start of the crabs' mating season.
[CLIP: Waves crash on the beach, and birds caw.]
Young: Standing on the shore of Norbury's Landing on a blustery mid-May afternoon, I watched this scene unfold.
Young (tape): So that one is attached and mating.
McKenzie: Yeah, so if she was over here laying eggs, it would be trying to fertilize the eggs, and—like right here: see how its claws are attached to her?
Young: The heavily armored crabs look a bit alien, and sometimes a bit silly, as they draw odd tracks in the sand like uncoordinated Roombas. The ancient arthropods burrow into the sand and lay millions of gelatinous eggs. Those eggs provide the perfect buffet for the migrating birds that need to bulk up before their next leg in their journey.
McKenzie: They're pretty thin though, so they'll be around for a while. They're not nice and fat.
Young: And Pam needs the birds to eat because she needs them to poop.
As time passes and the tide retreats, first the birds swoop in to feast, and then Pam comes in, hot on their trail of droppings. After 15 years of doing this work Pam has developed a special eye for bird poop. She can make a pretty good first guess of what poop belongs to the migratory bird she's most interested in.
McKenzie: Here's one. That's one. It's probably a sanderling, like, small—you know, it's small, so probably a small bird. So this right here, this is so crass [laughs], but it's like a little log, and ruddy turnstones tend to drop logs, so.
Young: Fresh poop is best—damp but not drenched from the tide. This increases the odds it'll contain live virus that can be sequenced back at the lab. Once Pam spots a promising, intact poo she'll use a swab to swiftly scoop the sample from the sand and into a vial.
St. Jude's research center holds a library of more than 20,000 viruses, including isolates of various iterations, or subtypes, of avian influenza collected from Delaware Bay and other locations around the world.
Influenza subtypes are generally classified based on two specific surface proteins: hemagglutinin and neuraminidase. They represent the H and the N in flu names you've probably seen, like the common seasonal flu subtypes H1N1 and H3N2.
There are 144 H and N possible combinations of avian influenza. And over the years the St. Jude team has detected nearly every subtype in fecal samples collected at Delaware Bay. That includes the subtype that's been on our minds a lot lately.
Webster: Amongst those was H5N1, indeed, but not from the European or Chinese ones.
Young: The particular shorebirds stopping by Delaware Bay might not be carrying the kind of bird flu that could be dangerous to domestic animals or humans. But with the right genetic mixing we could potentially see outbreaks of a new 'killer' strain like the one currently ripping through U.S. farms.
Since 2022 a deadly new strain of H5N1 has infected more than 170 million domestic poultry, according to the U.S. Department of Agriculture. The virus has raised our egg prices, led to the culling of millions of chickens and infected upwards of 1,000 herds of dairy cattle since March 2024.
But to really understand the high-pathogenic H5N1 in our cows and chickens—and where it might go from here—we have to go back in time and look at wild birds.
Young: Wild birds, particularly aquatic birds, are hosts, or reservoirs, of different influenza viruses. They're categorized as either low-pathogenic or highly pathogenic, depending on how well they cause disease in chickens. A highly pathogenic, or 'high-path,' virus, as many influenza researchers like to call it, can wipe out an entire poultry flock in just a few days.
The earliest records of high-path avian influenza are believed to come from the late 1800s, when what was known at the time as 'fowl plague' ripped through poultry in Europe. Sporadic spillovers from wild to domestic birds have continued ever since.
Keiji Fukuda: In the influenza field it was clear that there was a very large group of influenza viruses, which infected birds and sometimes infected animals, and then there was a much smaller group of human influenza viruses, which infected people.
Young: That's Keiji Fukuda, a retired physician and influenza epidemiologist who worked for various institutions, including the University of Hong Kong, World Health Organization and the U.S. Centers for Disease Control and Prevention.
Fukuda: We thought these were separate groups of viruses and that animal influenza viruses did not infect humans.
Young: That changed in 1997, when a previously healthy three-year-old boy in Hong Kong was hospitalized and developed a severe pneumonia. Six days later the boy died. Influenza researchers around the world were called upon to help identify the exact type of virus. Robert was one of them.
Webster: It couldn't be identified at CDC. It couldn't be identified in London or in Holland, where they sent it, and they applied to me for the whole range of influenza virus reference serum, and they identified this virus as an H5, an H5N1. And no one would quite believe that this virus had killed the child.
Young: That shocked scientists and public health leaders, including molecular virologist Nancy Cox. She's retired now but worked at the CDC from 1975 to 2014 and was leading the agency's influenza branch in 1997.
Nancy Cox: We didn't expect to see high-path avian influenza viruses infecting humans. We just didn't expect that. We hadn't seen it before. It was really quite out of left field.
Young: Questions started flying rapid-fire.
Fukuda: How could this boy have become infected?
Cox: Where'd this virus come from? Could it have been a laboratory contaminant from eggs that had come in from an infected farm?
Fukuda: Was this boy associated with any kind of unusual exposures?
Cox: Were there other cases that had yet to be identified in Hong Kong?
Young: Everyone hoped the child was a tragic one-off case. But a few months later their worst fears became a reality: more people developed H5N1 infections.
Keiji, who was also with the CDC at the time and had worked with local public health officials on the ground on the first case, returned to Hong Kong.
[CLIP: A reporter interviews Keiji Fukuda during a 1997 press conference: '[Is there a] possibility this virus could, could become stronger in, in terms of its efficiency?']
[CLIP: Fukuda responds to the reporter: 'Well, by stronger, you mean it could become more adapted to humans and sort of pass through? Yes, there is that possibility.']
Young: That was younger Keiji back in 1997, talking to a reporter at a press conference in Hong Kong as the outbreak was unfolding.
Fukuda: We're dealing with a virus which has remained persistent for at least some period of time, and we have no idea: 'Is this the beginning of another pandemic?' And the investigations took on a whole different flavor. It was very serious.
Young: Keiji says the team eventually determined that the virus seemingly spread through traditional live bird markets, often referred to as wet markets. As is the case in many Asian cultures it is common for people in Hong Kong to purchase fresh poultry, including chicken, duck and goose, that is often killed on-site.
Guided by public health advisers, government officials ordered that the markets suspend sales and get cleaned—and that farms and markets cull all poultry.
Fukuda: At that time it was a very kind of disquieting decision and implementation. You know, we had never before recommended the culling of such a large number of birds.
Young: Although it was a brutal decision for farmers and sellers the tactic worked, effectively squashing an outbreak that seemed on the verge of taking off. By the end of the outbreak six people had died of the 18 with confirmed infections. Thankfully there was no evidence of human-to-human transmission, which is key to kick-starting a pandemic.
The genetic sequences of the virus also revealed genes tracing back to its likely reservoir: waterfowl, or geese. Here's Nancy.
Cox: What we saw at the very beginning of the H5N1 outbreak back in 1997 is that the viruses that we identified from poultry and from people were really very, very similar.
Young: But she says a lot has happened since the 1997 Hong Kong outbreak.
Cox: Now we've had this virus circulating globally, and what we're seeing is a huge amount of diversity, and what does that mean? It means that we have a lot more opportunities for the virus to develop the ability to infect humans more efficiently and then eventually, potentially, to become transmissible from human to human.
Young: As H5N1 has fanned across the globe over the years its activity has been a bit like a simmering volcano: occasionally waking up in dramatic spurts, only to go quiet again. And each time it flares up the virus gets a new opportunity to tweak itself—ever so slightly.
Wendy Puryear: During that whole 30-year time period there continued to be ongoing evolution and shifts and changes in the virus.
Young: Wendy Puryear is a scientist studying influenza evolution and adaptation at the Cummings School of Veterinary Medicine at Tufts University.
Puryear: It's an RNA virus, and that means that it is sloppy in the way that it replicates, so there's constantly slight changes that are being introduced every time that virus goes through a replication cycle.
Young: Wendy's research at Tufts focuses on the surveillance of different subtypes of influenza and wildlife. She's been watching with increasing unease how changes, or mutations, are creating a vast diversity of H5N1 viruses—including ones that might be better at infecting different animals.
Puryear: Prior to the COVID pandemic the thing that many of us were very concerned would be the next pandemic of large impact on human health was influenza. So this is one that we've been worried about for a long time.
Young: Wendy says H5N1 keeps hitting mutation milestones that are getting too close for comfort.
Puryear: We keep going further down that road of 'at least it hasn't.'
'At least it hadn't gone into a lot of wild animals and was disseminating around the globe.'
Young: Now lineages of the virus have been detected in animals in nearly every continent. H5N1 has established itself in domestic poultry in various countries in Asia, the Middle East, the Americas, Africa and Europe.
And [starting] a few years ago the number of bird species carrying H5N1 has ballooned. More than 500 different avian species, ranging from seabirds to songbirds, have tested positive for H5N1, according to the Food and Agriculture Organization of the United Nations.
Puryear: ' Well, now it is. Well, at least it wasn't going into mammals.'
Young: Then around 2020 and 2021 highly pathogenic H5N1 started to infect different mammals, to date affecting more than 90 different species in total, including coyotes, minks, opossums, skunks and rodents.
The virus had previously been found in the occasional fox or tiger, typically predators that might've eaten an infected wild bird. But the list of newly infected mammal species is growing in a way that hasn't been seen before.
Pruyear: 'At least there wasn't evidence of mammal-to-mammal transmission.' Well, then we had that in marine mammals in South America.
Young: In 2022 and 2023 the virus spread among various marine animals along the coast of Peru and Chile, killing more than 30,000 sea lions. It happened so rapidly that scientists suspected it must have traveled directly between animals.
The virus made its way around to the Atlantic coast. Groups of dolphins, porpoises and otters were also infected.
Puryear: 'Well, at least it's not in a context that we're in close proximity between humans and those mammals.' Well, now it's in dairy cattle.
Young: No one expected the virus to hit U.S. dairy cows. How it got onto farms in the first place is still a bit of a mystery; you'll hear a lot more about that in the next episode of this three-part series. But it's important to say that scientists do have a strong hunch about how the virus made that jump—and you probably guessed it: wild birds.
Louise Moncla: There's this whole diversity of low-path viruses that don't really cause as many problems that circulate endemically in these wild birds in North America.
Young: That's Louise Moncla. She's a pathobiologist leading a lab at the University of Pennsylvania that's building a family tree of avian influenza viruses.
Moncla: Through this process called reassortment this incurring kind of new virus that entered started mixing with those viruses, and so we now have this diverse mixture of viruses sort of circulating in wild birds, resulting in the emergence of these new genotypes ...
Young: New genotypes, or unique genetic profiles, like the high-path H5N1 that scientists think started infecting dairy cows. This genetic mixing, or reassortment of different influenza viruses, occurs when they co-infect one host: a bird, an animal or, worse, a human. That opens up the window for genetic information to be exchanged.
Here's Wendy again to unpack a bit of what Louise said.
Puryear: Not only do you have this regular evolution that happens with the virus being sloppy in how it replicates, but the fact that it has its genome on separate pieces, its genetic information is actually—those genes are on separate chunks of, of RNA, and that means that it can take a whole gene and swap it out with a different form of influenza, so that gives a whole new kinda Frankenstein version of the virus that can then move forward.
Young: And this process of virus info swapping can potentially spiral into something much bigger—and deadlier.
Here's Louise again.
Moncla: Reassortment is a really important process for influenza evolution because it has led to every past pandemic that we know about. So we usually get influenza pandemics when viruses from two different species mix via reassortment and [that] results in a virus for which a host population like humans doesn't have any prior immunity.
Young: But those viral swap meets leave footprints—clues that help researchers like Wendy and Louise track influenza evolution through time and space. Louise's flu family tree models, for instance, allow for real-time tracking of noteworthy genetic changes in H5N1. The tree's branches show small shifts from the virus's sloppy reproduction and the big evolutionary leaps from reassortment.
Moncla: If you sample and sequence those viral genomes, you can use those mutations to link cases together. So these genomes provide this nice little map of how this virus has been moving between different host species or populations or geographic areas.
Young: And wild birds help paint a picture of where the virus might be now and where it might go next. These feathered virus carriers have effectively moved influenza around the world and into our domesticated animals.
But Louise, Wendy, Nancy, Keiji and folks at St. Jude are all quick to say that migrating birds and wildlife shouldn't be blamed for H5N1's current stronghold—it's the way that humans monitor and respond to the situation.
Moncla: Now that these viruses are really being driven by transmission of wild birds we need to understand how these viruses evolve in wild birds a lot better. And so something I'm really hoping continues to happen is surveillance in wild birds. You know, so without this kind of continuous surveillance effort in wild birds we wouldn't have been able to understand the outbreak in dairy cattle or these human spillovers and where they're coming from.
Young: Wild birds can't be stopped, but they can be watched—just like how the St. Jude group is surveying the shorebirds at Delaware Bay, year after year.
[CLIP: Birds caw.]
Young: Back in Delaware Bay, armed with vials of bird poop and a compact scientific camper van, another virus hunter is doing exactly that.
Lisa Kercher: My name is Lisa Kercher. I am the director of laboratory operations for the Webby Lab group at St. Jude Children's Research Hospital, which is a—our lab group is a large influenza research laboratory.
Young (tape): Great, and tell us where we are right now.
Kercher: Yes, we're sitting in a 19-foot toy hauler that is a trailer camper that has been built out to work as a molecular biology lab.
Young: Lisa lives part time in her truck and camper, living and sleeping alongside carefully stored poop samples preserved in cold liquid nitrogen. The space is a cozy fit for the two of us and her sweet English Labrador retriever, Jax.
Like a lot of campers it's got a small kitchen, bathroom and a very comfortable bed, according to Lisa, but she's customized the space with a makeshift lab bench.
Kercher: I have like already shattered the door once and had to have it replaced.
Young (tape): No...!
Young: Her working area is stocked with protective gear, reagents, pipettes, well plates and a variety of miniature equipment, including a PCR machine that can quickly amplify DNA from samples Pam collected the day before.
Kercher: It can then immediately run a PCR for flu and for H5, and I know on my little laptop here if that's positive within about an hour. And so by the time I'm driving home I have the prevalence of the flu that was in these shorebirds for the time I was here. So it's a great first step.
Young: At that point in site collecting she had processed 250 fecal samples. By the end of the week the team will have collected 1,000. Later the samples will be transported to St. Jude's main labs in Tennessee to verify Lisa's initial readings.
Before she started doing this real-time surveillance work two years ago, the team wouldn't know what avian influenza subtypes they had on their hands until about six months after the sample collections.
Kercher: It's very hard to do epidemiology of how the virus is moving and tracking when you spend six months waiting for the sequence to come out of a national lab or any big lab. It's just hard logistically to then backtrack and figure that out. You can do it, but it's usually a year later. And then you are usually faced with a whole different virus by that time. So the point of doing it faster is so that you can do risk assessment in more real time.
Young: But if Lisa wants to be really fast, she needs more data. The poo samples from the beach are valuable sources of viral sequences, but they can't offer the full flu picture.
Kercher: So when you get a flu virus from a fecal sample you have to give it a name, you have to same say the species that it came from. How do you know?
Young: Like solving any mystery the researchers want to answer the big whodunit—or in this case, who- dung -it.
Knowing the exact bird species that pooed the poo requires more testing and more time, and it's not something that she can do from inside the camper lab. That's why Lisa is teaming up with local wildlife ecologists. Enter Larry Niles and his bird-catching cannon.
Larry Niles: Most of those noises are from the sanderling. We caught almost 100 sanderlings.
Young (tape): Wow.
Niles: We caught a handful of [red] knots and ruddy turnstones.
Young: The day before visiting the mobile lab I was on the beach with Lisa and Larry. He co-leads the Delaware Bay Shorebird Project with Wildlife Restoration Partnerships. Larry has been catching shorebirds here as part of his conservation work for the last 29 years. And yes, his group uses something called a cannon net to nab these birds because ...
Niles: See, shorebirds very difficult to catch because they're hard to get close to because they're used to being out on flats like sand flats. Today we used two cannon, and see, the advantage of that is: the net, which is about 40 feet [roughly 12 meters] long, when we hook it up to the cannons, that net goes so fast that it gets over the birds before they have the time to react.
Young: The birds are temporarily corralled in cloth-covered boxes, waiting for Larry and the other researchers and volunteers to gently pull them out to collect various data points. They'll measure the birds' wings and beaks, weigh them and take a blood and feather sample before they're released back to the horseshoe-crab-egg feast on the beach.
And though Larry has his own research to do on the ecology of the birds—their health, their population numbers and what might threaten those things—he says it's a real bonus to have virus detectives like Pam and Lisa to work with, side by side.
Niles: I'm not a virologist; I'm an ecologist. But I understand the ecology of things, and I think melding the ecology of birds with the ecology of these viruses, that's our part—working with the virologists so that together we could figure it out.
Young: For Lisa, getting access to the shorebirds directly unlocks all sorts of crucial information.
Kercher: So, when you're getting the samples straight from the birds then you already know the species, so that just makes it a little bit easier.
Young: And it's along these migratory routes, called flyways, where the birds, the ecologists and the virologists with camper labs need to meet.
Kercher: When the avian virus jumps into a mammal it has the opportunity to mutate into becoming more mammalianlike, and that is why we are so concerned in the flyway.
Young: There are four main flyways, [also] called avian superhighways, that run through North America. Since getting her mobile lab up and running Lisa has driven it thousands of miles up and down these flyways to sites in Alberta, Canada, and northwest Tennessee. But these avian superhighways have also become increasingly concerning for H5N1.
Kercher: Those birds are carrying this virus in greater numbers and in lots more areas where there's potential for spillover into domestic poultry farms. And of course, this happened in the dairy farms—it spilled over into the cattle, so this virus is now very prevalent all over North America. But the flyways are important because the birds that carry it are moving quickly down the flyway in a very short period of time, and you have a lot of opportunity for spillover there.
Young: Lisa says that speed matters for a rapidly changing virus like H5N1. She could imagine her mobile lab getting scaled up into a large biosurveillance network: multiple satellite labs dotted up and down all the flyways, relaying genetic sequences to other influenza trackers like Louise and Wendy but also to farmers on the ground trying to keep their chickens and cows healthy.
Kercher: Wouldn't it be great if the farmer had a way to go on his computer and look at a dashboard and say, 'Wow, I wonder where the flu is?' They need to know where it is circulating in the wild birds. And if they knew where it was ahead of time—or at least where it was coming from—they would have an opportunity, if they chose, to up their biosecurity a little bit.
Young: Until then virus detectors like Pam and Lisa continue to keep a watchful eye on the surprising twists and turns of H5N1, looking to the birds and the clues they leave behind.
Kercher: We'll never catch up with Mother Nature. We're never gonna catch up with the virus and how it mutates. But if we can get closer and approach it more, you can then look for mutations, much quicker things that make the virus resistant to antivirals or things that make it more mammalian adaptable. You would wanna know that sooner rather than later.
Feltman: That's all for today's episode, but there's lots more to come. Tune in on Wednesday for part two of our special series on bird flu, which explores how avian influenza made its unprecedented leap into cattle.
Science Quickly is produced by me, Rachel Feltman, along with Fonda Mwangi, Kelso Harper, Naeem Amarsy and Jeff DelViscio. This episode was reported and hosted by Lauren Young and edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check our show. Our theme music was composed by Dominic Smith. Special thanks to Michael Sheffield at St. Jude; the volunteers and collaborators with Wildlife Restoration Partnerships; and Kimberly Lau, Dean Visser and Jeanna Bryner at Scientific American. Subscribe to Scientific American for more up-to-date and in-depth science news.
For Scientific American' s Science Quickly, I'm Rachel Feltman. See you next time!
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
a day ago
- The Hill
Heat dome passes, but climate-fueled waves aren't going anywhere
Climate change is making heat waves like the one that lingered over much of the U.S. this week more frequent and intense. The Eastern U.S. sweltered under a heat dome in recent days, with some cities surpassing 100 degrees Fahrenheit. Roads in Delaware, Wisconsin and Missouri buckled, while a Virginia bridge malfunctioned and dozens of people in places including Washington D.C. and North Carolina were reportedly hospitalized. In New Jersey, some 100 people were treated after attending outdoor graduation ceremonies in the extreme heat. And while summer is always hot, man-made climate change is worsening the problem. Temperatures in parts of the country are set to soar again this coming week. Megan Kirchmeier-Young, a research scientist at Environment and Climate Change Canada, told The Hill that as the planet warms up in a broader sense, extreme heat events become more likely. 'Warming, from human-caused climate change, means more days when we exceed particular temperature thresholds. Across most of the globe, hot extremes are becoming hotter and occurring more often. And we expect these trends to continue with continued global warming,' Kirchmeier-Young said in an email. 'While we do not yet have results for this week's event, Environment and Climate Change Canada's rapid event attribution system analyzed many heat waves from last summer and found that all were more likely to occur because of human-caused climate change,' she added. And not only is the entire planet warming, the Arctic is warming even faster. Because of this, said Jonathan Overpeck, dean of the School for Environment and Sustainability at the University of Michigan, the jet stream slows down and becomes curvier. 'This is where you start to get these high-pressure domes that just sit in one place longer,' he said, adding that 'these very hot events are becoming more frequent because of that; they concentrate the heat in one large region.' Michael Mann, a professor at the University of Pennsylvania's earth and environmental science department, said in an email that the heat domes being experienced by the U.S and Europe 'show that this was part of a very large-scale pattern, associated with a very 'wiggly' jet stream where the 'wiggles' stay in place for days on end.' 'It's really a double whammy, the basic effect of warming the planet, plus how the pattern of warming is changing the jet stream, giving us those stuck, weather extremes, like the heat domes,' Mann said. He's one of the authors of a paper published earlier this year that found that there has been a 'threefold increase' in such events over the last 70 years, which has been 'closely tied to amplified Arctic warming.' 'You're potentially looking at that trend simply continuing on toward quadrupling, etc., as long as we continue to warm the planet with carbon emissions,' Mann told The Hill. Kirchmeier-Young provided a different perspective, saying there's some uncertainty in how weather patterns are changing. 'The main factor for increases in the intensity and frequency of hot extremes is increasing temperatures. While specific weather patterns are important for the occurrence of any particular heat wave event, if/how these weather patterns might be changing is much more uncertain,' she said. But it's not just the heat that causes misery during a heat wave, it can also be the humidity — something that Overpeck also said is being exacerbated by climate change. 'The atmosphere, because it's warmer, it holds more moisture. And it's that combination of the higher humidity, the water in the atmosphere and the heat that really makes it bad,' he said. The world's average global temperature has already risen 1.36 degrees Celsius, or about 2.4 degrees Fahrenheit, when compared to preindustrial times, primarily due to manmade activity such as the burning of fossil fuels. But this is just a global average, and what people experience may be significantly hotter than just a few degrees. 'We still have warmer days and cooler days, but we are shifting the baseline, so the warmer days are even hotter than they used to be,' said Kirchmeier-Young. 'It will not take much warming in the global temperature to see notable changes in extremes at the regional scale.' 'The average temperature of the planet is hard to feel, but for comparison, if we cooled the planet by four to five degrees C, we'd have an ice age, and that would be a totally different planet,' said Overpeck. The heat wave came as the Trump administration is rolling back regulations meant to mitigate climate change — and as Congress prepares to repeal climate-friendly policies and incentives as part of Republicans' 'big, beautiful bill.' 'This heat wave that we're just coming out of is a great example of we're going to see more of getting even hotter and longer if we don't slow down our use and stop our use of fossil fuels and replace fossil fuels with … clean, low-carbon energy,' Overpeck said.


Scientific American
2 days ago
- Scientific American
Science Quiz: Synesthesia and Superconductors
Allison Parshall is an associate editor at Scientific American covering mind and brain. She writes the magazine's Contributors column and weekly online Science Quizzes. As a multimedia journalist, she contributes to Scientific American 's podcast Science Quickly. Parshall's work has also appeared in Quanta Magazine and Inverse. She graduated from New York University's Arthur L. Carter Journalism Institute with a master's degree in science, health and environmental reporting. She has a bachelor's degree in psychology from Georgetown University.


Scientific American
2 days ago
- Scientific American
This is How We Fight Bird Flu If H5N1 Becomes the Next Human Pandemic
Rachel Feltman: For Scientific American 's Science Quickly, I'm Rachel Feltman. This is the final episode of our three-part series on bird flu. On Wednesday we met scientists who are getting their hands dirty with dairy cows and poultry to better understand how H5N1 bird flu is spreading. Today we'll take a look at efforts to create vaccines for H5N1—and learn why eggs are so critical to the vaccine-making process. Our host today is Naeem Amarsy, a multimedia journalist based in New York City. Here's Naeem now. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Naeem Amarsy: It's barely 10 A.M. in San Antonio, Texas, and it's nearly 90 degrees—in the middle of May. While the rest of the city steps out in sandals and shorts, I'm watching a team of scientists at Texas Biomedical Research Institute. They're rummaging through metallic shelves to find the extra layers of protective gear they need to start their day: scrubs, gowns, gloves, shoe covers, hairnets and long white coveralls. Luis Martinez-Sobrido: So, we need to change all our clothes. That's why we have all these cabinets there. Amarsy: That's virologist Luis Martinez-Sobrido. He observes with a keen eye as two members of his lab dress up for their next shift. Martinez-Sobrido: You take everything out—only the scrubs and the bunny suit. They also use this head net to cover the head. I don't have that problem. I don't need that [laughs]. Amarsy: Luis's team is preparing to enter a BSL-3—which is short for biosafety level three—facility. In these highly secure labs scientists handle some of the world's potentially deadliest viruses. Martinez-Sobrido: So mainly here we are working with tuberculosis, we are working with SARS-CoV-2 and H5N1. Amarsy: H5N1 is the reason I am here. As we learned in the first two episodes of this series the virus is moving between species, from wild birds to their domesticated counterparts to cows and other mammals. And now it's reached humans. The currently circulating strains have already infected dozens of people, mostly poultry and cattle farmworkers. Luckily, most of these infections have been mild. But historically, H5N1 viruses have killed nearly 50 percent of the people they've infected, according to the World Health Organization. And that's a major concern. The more these H5N1 viruses circulate, the greater the chance they change into forms that cause severe disease—and that easily spread between people. Martinez-Sobrido: We do not have any preexisting immunity against this H5N1 virus, and if it's able to transmit, it will potentially cause a pandemic. Amarsy: I wanted to understand what virologists like Luis are discovering about bird flu and how they might try to protect us if it does start jumping between humans. Inside the anteroom, a sealed space between the outside world and the BSL-3 lab, each of Luis's colleagues puts on their final piece of equipment: a battery-powered respirator connected to a large white hood with a transparent front that they call 'the bubble.' Ahmed Elsayed: So we start with checking our bubble and connecting the battery. [CLIP: Elsayed's respirator battery makes a noise as it's plugged in.] Elsayed: And then start the bubble. [CLIP: Elsayed's bubble beeps.] Elsayed: Then we connect the shroud that we put to protect our face. Amarsy: That's Ahmed Elsayed, a staff scientist working in Luis's lab. In his immaculate white coveralls he reminds me of a beekeeper. At the back of his head a thick cable connects his bubble to the air filter around his belt, it's a lifeline from any contagion inside the lab. Elsayed: We are waiting to have everyone ready before opening the second door because we cannot open it twice. So once everything is fine then we enter the PIN number and enter the lab. [CLIP: Elsayed types the entry code into the PIN pad. The PIN pad beeps, and the lab's second door opens and shuts.] Amarsy: As they disappear into the lab I am left wondering what Ahmed and his [colleagues] will do over the next six hours of their shift, working with those potentially deadly viruses. So I ask Luis. Martinez-Sobrido: So the main specialty of our lab is reverse genetic approaches, and reverse genetics mainly refer to the ability to generate recombinant viruses in the laboratory. It's not a virus that has been isolated from an animal or from a human. Amarsy: Recombinant viruses are one of the most powerful tools in virology. They let scientists like Luis use genetic sequences to re-create and modify viruses found in the wild—all that without having to rely on samples from the outside world. This helps researchers test a bunch of things about viruses such as H5N1, from how they respond to antiviral treatments to how they mutate and how sick they can make us. Martinez-Sobrido: More importantly, like in the case of the influenza vaccines, allow you to generate attenuated forms of the virus that then you can use as vaccines for the treatment of viral infections. Amarsy: Every year tens of millions of Americans get a flu shot. This prevents tens of thousands of hospitalizations. And making the annual seasonal flu vaccines is a coordinated global effort. The World Health Organization offers recommendations on the vaccines' makeup twice a year—in February for the Northern Hemisphere and September for the Southern Hemisphere. They make these recommendations based on which strains experts think are most likely to spread. In the U.S., the Food and Drug Administration considers that data and then makes its own recommendations, which pharmaceutical manufacturers use to produce millions of doses that are distributed across the country. Along the way, labs like Luis's get involved. Martinez-Sobrido: Well, we generate some of the stocks, or the seeds, of the vaccine. we cannot produce vaccines for a large population; we just do it [on a] smaller scale here. Amarsy: What Luis calls the 'seed' of the vaccine is a specifically designed virus that pharma companies use to develop flu vaccines. It doesn't make us sick but instead helps our body create antibodies. It's also known as a candidate vaccine virus. Amarsy (tape): So if I get a flu shot at the end of the year ... Martinez-Sobrido: It could be coming from here, yeah. Amarsy: In addition to its contribution to your annual flu shot, Luis's lab makes candidates for potential vaccines to protect against H5N1. These so-called pandemic vaccine viruses are an essential line of defense against the threat of an avian flu pandemic. They can be used to create vaccines to help reduce severe illness. And whether we're talking about flu shots for seasonal or avian strains, making them usually involves a surprising tool. Martinez-Sobrido: We infect eggs with the virus. Amarsy: These aren't your everyday supermarket eggs. They are fertilized eggs, produced in secret biosecure farms across the country. It's believed that we go through millions of these eggs every year. They are used because flu viruses grow very well in the allantoic cavity, which is full of a liquid that contains waste from the embryo as well as various proteins. Luis and his team showed me how they make H5N1 vaccine seeds. They said it all starts in their super-secure BSL-3 lab that only authorized researchers can enter. I can't go in. Martinez-Sobrido: So, we usually start with a vaccine virus that we generate in the laboratory. It does not infect or replicate [in] humans, but it grows very well in eggs. Amarsy: Once the scientists create the virus they conduct a bunch of tests to make sure it actually isn't dangerous to humans. Only when they know the virus is safe do they move it to another lab with less stringent safety rules—no need for respirators—and this time I could join. Martinez-Sobrido: We have egg incubators like these where we keep the eggs inside, and they actually rotate, like, every 15 minutes, 20 minutes. [CLIP: The incubator rotating.] Amarsy: Ahmed removes a dozen white eggs from the incubator and turns off the ceiling lights. Elsayed: So we get the egg at day one, so then we keep it until day 10, [when] the embryo will be ready and the egg will be ready for infection to propagate the viruses. So now we will start to candle the egg. Amarsy: He holds an egg in one hand. He moves the egg below a small light attached to his workstation, causing it to glow orange—except for a small circular patch at the top, which remains white. That's the air sac, he explains. He wants to avoid injecting the virus there because it won't grow. [CLIP: Elsayed marks an egg's air sac.] Elsayed: Then we find [a] certain point in which we can use to inoculate safely the embryonated egg without affecting the embryo. Amarsy: After labeling a dozen eggs Ahmed turns the lights back on. He passes the crate to Ramya Smithaveni Barre, a Ph.D. student who also works in Luis's lab. Ramya Smithaveni Barre: We will actually be making a hole here at the point, and we will be injecting the virus into the allantoic fluid. Amarsy: Under a loud biosafety hood she pokes small holes into the eggs and injects them with the specially designed vaccine virus. Barre: These are 18-gauge needles. These are very thick, so it just helps drill a hole quickly. So just make a hole here. So you see this point here, which—where the X mark is made? So from here we will be injecting using a syringe. [CLIP: Barre opens a syringe packet and injects virus into an egg.] Barre: So after this is done I will basically be covering them with the glue to seal them.... So after that they go into the incubator, and they stay there for, like, 48 hours. Amarsy: Now that the eggs have been infected the team needs to wait for the virus to propagate in large enough quantities. In two days they will extract the allantoic fluid, which now contains the virus, conduct a number of tests and put the samples with the highest virus concentration into vials. Each has enough virus to make thousands of flu vaccine doses. After leaving Luis's lab the vials go through a series of quality control evaluations and testing. And then they'll be sent to manufacturing labs, which, in the case of a pandemic, can use them to replicate the process in millions of eggs. Martinez-Sobrido: Since this is a virus that is still alive the next thing they do after growing the virus is to kill the virus, inactivate the virus. So once they inactivate the virus they process [it], and then they put it in the tube, and then they send it to the pharmacy, and that's what you get. Amarsy: For the 2024–2025 flu season the CDC said it expected about 80 percent of flu vaccines in the U.S. to be made using the egg-based method. And without the science that has—even if most people don't know it—gone into every flu shot you've ever had, we might not be able to prepare for what scientists say is the growing threat of a potential bird flu pandemic. Martinez-Sobrido: We recently are aware of how important the vaccines are because of the COVID-19 pandemic, right? That these vaccines have clearly saved millions of lives. But, clearly [this] is the best mechanism that we have to protect us against any type of infectious disease, including influenza. Amarsy: And if H5N1 does become easily transmissible between humans, the seeds that Luis's lab makes and the H5N1 vaccines that follow, could become central to our pandemic response. Amesh Adalja: So there are stockpiled vaccines against H5N1. This is a process that began during George W. Bush's administration. These are not well-matched to what's circulating now, but there have been efforts to update that stockpile. There's not enough in the stockpile currently to vaccinate the entire U.S. population. There are efforts underway to increase that stockpile if needed, and there are contracts in place to be able to do that. In the event of a threat change you would anticipate manufacturers coming online and some of the seasonal flu capacity being shifted to pandemic flu requirements. Amarsy: That's Amesh Adalja. He's a pandemic-preparedness specialist at Johns Hopkins University and an infectious disease physician. Amesh emphasizes the importance of vaccines as one of our first lines of defense against a potential avian influenza pandemic. But he sees some challenges in our current system. Adalja: The issue will always be: Does the vaccine work very well? Is it well-matched to what—the strain that's circulating or that's causing the issue? And how much of it do we have, and how fast can we have it in the arms of those people who are at most risk? Amarsy: Part of what complicates addressing these concerns is the use of chicken eggs, he says. Adalja: If you're in an avian influenza outbreak, it might affect chicken farms and chicken egg production. However, people recognize that, and there have been specific flocks that have been segregated away and kept under high biosafety to not allow them to be infected. They're not kept in [the] open, where a passing goose can't put its droppings in the chicken cage. The individuals that have to interact with them have to wear aggressive personal protective equipment. Amarsy: So to experts like Amesh, threats to egg availability aren't the main problem. The larger concern is that creating vaccines by using chicken eggs takes so long that scientists have to pick the strains about six months before a vaccine gets into our arms. Adalja: And that creates a problem because when they're making that strain selection, things might change later in the season, and they're pretty much stuck with what they picked. So that's why we sometimes have vaccine mismatches: because of that long lead time required by the egg-based vaccine manufacturers. Amarsy: This means that if the H5N1 viruses currently circulating were to mutate into a new strain that doesn't respond to the vaccine seeds made in labs like Luis's, it would be at least half a year before we even had egg-based shots available. By that time many people could already be infected. Additionally, Amesh says there's another problem with growing bird flu vaccines in eggs. Adalja: When you propagate the virus in chicken eggs, the virus mutates and you might end up at the end with something different than what you started with that might not work as well, so I think it also decreases the efficacy. So, long lead time, which allows mismatches to occur more frequently, and you get egg-based mutations that decrease the efficacy of the vaccine. Amarsy: As mentioned before we still use eggs to make most flu shots, and most of the time it works well. It's the cheapest option, and we have a widespread manufacturing infrastructure built around this process. But there are also quicker alternatives, like cell-based vaccines, which are grown in mammalian cells. And though these approaches cost more right now, experts like Amesh have advocated for them to be adopted more widely. Some labs are trying to develop even newer solutions based on messenger RNA, like many of the COVID vaccines. This process could allow countries to deploy a vaccine that matches a new strain much quicker. The Trump administration, however, recently canceled $766 million in funding for the pharmaceutical company Moderna to develop an mRNA-based bird flu shot. This has added to concerns about the U.S. Department of Health and Human Services' approach to vaccination. But for H5N1 to trigger the next pandemic it would need to acquire the ability to easily transmit between humans. And that, we think, hasn't happened yet. Adolfo García-Sastre: We have these little entities, microscopic entities, viruses—flu has only eight genes, eight genes, and they get inside a cell of an organism that—we have [about] 30,000 genes. And how [is] the virus ... able to—these eight genes [able to] code information that take over the whole 30,000 genes and then change completely the cell to make copies of themselves? How can you achieve that with so little information, right? That's fascinating. Amarsy: That's Adolfo García-Sastre. He's one of the world's leading flu virologists, and he trained Luis back in the 2000s. He now runs a lab at the Mount Sinai Icahn School of Medicine in New York City. His lab looks at pretty much everything that has to do with flu—vaccination, treatments, viral evolution, transmission, mutations—but even he was surprised by what H5N1 has done. Amarsy: As we heard my colleague Meghan Bartels explain in Episode Two, scientists were astonished when they learned that H5N1 had jumped from birds to cows. And now the big fear is that the virus manages to adapt well enough to our bodies to transmit efficiently between people. One way that could happen is through reassortment, the genetic mixing of multiple influenza viruses that we learned about in episode one. García-Sastre: So if we get, for example, the 2009 H1N1 pandemic of flu, ... it [had acquired] gene chromosomes coming from four different viruses: one was a virus circulating in humans, the other was a virus circulating in birds, the other virus circulating in pigs and the other virus circulating in pigs but [in] a different geographical area. So somehow these viruses got together into a pig and then created this particular virus. Amarsy: Another way H5N1 could develop the ability to move from human to human is by simply mutating. Mutations happen when viruses make copies of themselves and mistakes slip in. Most of the time the mutations that don't benefit the virus are less likely to pass down. García-Sastre: But it can happen that if a new mutation gives you a new characteristic that makes you more likely to replicate faster than your previous brothers and [sisters], then this mutation dominates. Now, let's say H5N1, if it requires 20 different mutations to replicate and transmit in humans and if each mutation by itself doesn't make it better, that is very rare because these 20 mutations, it's very difficult [for them to] happen at the same time. But if it requires only four mutations, that's a different story. Maybe you can get four mutations being [generated] at one moment and it just [happens] to be that this—there is a human that gets infected with this mutant virus; then it starts to propagate in humans. Amarsy: There's an ongoing debate among virologists about how many mutations it would take for the H5N1 viruses we are currently dealing with to better adapt to humans. One study found that for the strain that has been circulating in dairy cows since last year, one single mutation could potentially do the job. Here's what Adolfo had to say. García-Sastre: It's very unlikely because I think the number of encounters of this virus with humans has been so many that if it [would] be only one mutation required for [transmissibility] in humans, it would have happened already. Amarsy: Flu pandemics are historically very rare. But there's one notable exception: experts believe that in 1918 an H1N1 virus thought to have avian origins mutated in a way that made it better adapted to humans. Eventually, the virus caused one of the deadliest pandemics in recorded history, with estimates suggesting it killed anywhere from 50 to 100 million people worldwide. In 2005 Adolfo was part of a team that re-created this virus in the lab. And here's what they found. García-Sastre: So 1918 was always a, a mystery and a speculation [among] flu researchers. We realized that the virus was a very nasty virus to start with, and many of the deaths happened because that was an extreme case of a very virulent virus for humans of influenza. And that means that this can happen again, but will it happen again? When we started to try to understand what are the determinants of virulence of this virus, we found that it needed to have a perfect storm—a combination of multiple mutations happening in multiple genes of the virus—and only this combination makes the virus as lethal as it was. Amarsy: Just in the last roughly 140 years there have been five flu pandemics, ranging from the disastrous 1918 pandemic to the relatively mild 2009 outbreak. Virologists tend to agree that another flu pandemic is inevitable. But there's disagreement about how likely H5N1 is to be the trigger, so I asked Adolfo's longtime colleagues what they thought. Peter Palese: Some people think that it's just a question of time when any of these H5 ... they are bound to, to jump into humans. I turn it around and say, 'They have been with us so long already, in all kinds of animals—avian, mammalian—why hasn't it happened?' And so I'm not so sure it will happen, right? And I'm not so sure that this is the next pandemic strain, which will cause us all the grief, which we have seen with other pandemic strains. Amarsy: That's Peter Palese, Adolfo's mentor at Mount Sinai, and a leading figure behind a lot of innovations in influenza research. Florian Krammer: I think it's really hard to predict. You know, people were saying this would become a pandemic in 1997, in 2003 and since then very often, right? I think there is a high chance right now, or higher than before, just because there is so much virus out there and because it seems to adapt to mammals better. Amarsy: And that's Florian Krammer, who also works with Adolfo and Peter at Mount Sinai. García-Sastre: What is really clear is that there's gonna be another flu pandemic—doesn't need to be H5, but there have been, all the time, pandemics. Amarsy: It's not a foregone conclusion that H5N1 will trigger the next pandemic. But if it does, are we ready to respond effectively? I talked to epidemiologists Jennifer Nuzzo and Shira Doron. Here's what they told me. Jennifer Nuzzo: So h istorically, H5N1 has been observed to be one of the most deadly viruses we've seen. Meaning that of all the cases we've been able to find, about half of them have died, and that is truly extraordinary when you sort of rank pathogens in terms of their potential to kill the people that we know are infected. Amarsy: That's Jennifer. She directs the Pandemic Center at Brown University. Shira Doron: That has not been the case with the current strain. What we've seen with this particular strain is very mild illness, and so often what we're seeing with the individuals who have developed H5N1 influenza from cows and poultry is just conjunctivitis, or just conjunctivitis with some mild upper respiratory symptoms, like a sore throat. Amarsy: And that's Shira. She's the chief infection control officer at Tufts Medicine. From the beginning of the current outbreak to early June 2025 there have been 70 known human cases of H5N1 in the United States. And though most cases have been mild we made be undercounting them—by a lot. Doron: We know that our known cases are a relatively small proportion of total actual cases, especially because the disease has been so mild in most of the farmworkers who have become infected. Most people with very mild infection don't go to the doctor and don't request testing. Add to that the fact that many of these workers are undocumented migrants who are trying to stay under the radar. Amarsy: If many cases go undetected, it means that H5N1 could be spreading silently. And every time it infects a new person it gets a chance to mutate, possibly into a form that adapts better to our bodies. Nuzzo: I think it's quite concerning that we continue to see new outbreaks on farms being reported and yet no new human cases have been identified in months. So the number of animals who are getting infected continues to climb, and somehow the number of people who are being infected has just remained unchanged. We are also seeing that the amount of tests that states are doing has decreased. So we have a lot of reason to be concerned that we haven't found new cases because there's been a contraction in the surveillance efforts directed at H5N1. There may be lower H5N1 activity; I'm not ruling that out. But we also know that H5N1 is not going away. Amarsy: So in order to stay ahead of the curve Jennifer says we'd need to ramp up our monitoring efforts, from testing for possible infections to conducting wastewater surveillance. We'd also need to do much more to protect those who are most exposed to the virus. Nuzzo: We know just telling people to wear personal protective equipment to protect themselves against the virus every time they're around animals is not working because people have continued to get sick despite making those recommendations. So, I do think there is a case to be made to offer the vaccines that we do have to the agricultural sector—not mandate but offer—as another tool to protect them. Amarsy: Otherwise, we could be caught off guard. Nuzzo: H5N1 could be a lot less severe and still cause a tremendous amount of chaos and damage. You know, COVID-19 has [been] observed to be far less lethal than what we've observed H5N1 to be. And if H5N1 became able to infect people easily and able to transmit easily between people, thus triggering a pandemic, and anything close to the case fatality that we've seen it have, it would be far and away so much worse than anything we've ever observed with COVID-19. Amarsy: Of course, that's a scenario nobody wants. But if it happened, it's not like we'd be taking shots in the dark. As we learned from Luis we can make vaccines that are thought to be effective, at least against the current circulating strains of H5N1. Additionally, we have antiviral treatments, some of which researchers such as Adolfo and Peter have tested against the nastiest flu viruses, including viruses with genes from the 1918 strain, and they tend to work well against many different flu viruses. So what seems to concern epidemiologists such as Jennifer and Shira the most is not whether we have the right treatments and prevention mechanisms available to fight bird flu. Instead, the question is whether we have enough resources right now to handle another pandemic. Doron: We have tested a number of strategies and figured out how to do some really hard things, and those are triggers we could pull again if need be. So for example, in my hospital, we now know how to set up, very quickly, a mass testing site, a mass vaccination site. We know how to expand intensive care and expand patient care, so in some ways we're more prepared today because of COVID-19. Amarsy: But in other ways we are less prepared, the experts say. Nuzzo: The thing that I'm most worried about is the loss of experienced personnel. During the start of COVID-19 one of the things that states tried to do was contact tracing, but it was really hard because states didn't have the kind of personnel. So there was a massive, quick effort to try to build that personnel. Now not only do we not have that workforce anymore, but we've also lost a lot of public health leaders. You know, it's like we had an enormous fire rip through the U.S. and we decided to systematically dismantle all of the fire departments. So I am deeply worried about how the U.S. would fare in another pandemic. Amarsy: Jennifer says that sooner or later there will be another flu pandemic. Whether it will be caused by H5N1 or another bird flu virus, we just don't know. But the way we prepare today, from the vaccine seeds built in labs like Luis's to the critical research conducted by Adolfo to the care administered in Shira's hospital, will determine how strong our response is—and whether the next outbreak will upend our world. Feltman: That's all for today's episode. We hope you've enjoyed this week's special series on bird flu. We'll be back with something new on Monday. Science Quickly is produced by me, Rachel Feltman, along with Fonda Mwangi, Kelso Harper, Naeem Amarsy and Jeff DelViscio. This episode was reported and hosted by Naeem Amarsy and edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check our show. Our theme music was composed by Dominic Smith. Special thanks to Laura Petersen and Catie Corcoran at the Texas Biomedical [Research] Institute; Jane Deng and Elizabeth Dowling at the Mount Sinai Icahn School of Medicine; and Kimberly Lau, Dean Visser and Jeanna Bryner at Scientific American. Subscribe to Scientific American for more up-to-date and in-depth science news. For Science Quickly, this is Rachel Feltman. Have a great weekend.